Global Pharmaceutical Contract Manufacture Organization Market Growth (Status and Outlook) 2023-2029
LPI (LP Information)' newest research report, the “Pharmaceutical Contract Manufacture Organization Industry Forecast” looks at past sales and reviews total world Pharmaceutical Contract Manufacture Organization sales in 2022, providing a comprehensive analysis by region and market sector of projected Pharmaceutical Contract Manufacture Organization sales for 2023 through 2029. With Pharmaceutical Contract Manufacture Organization sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pharmaceutical Contract Manufacture Organization industry.
This Insight Report provides a comprehensive analysis of the global Pharmaceutical Contract Manufacture Organization landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pharmaceutical Contract Manufacture Organization portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Pharmaceutical Contract Manufacture Organization market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pharmaceutical Contract Manufacture Organization and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pharmaceutical Contract Manufacture Organization.
The global Pharmaceutical Contract Manufacture Organization market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pharmaceutical Contract Manufacture Organization is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pharmaceutical Contract Manufacture Organization is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pharmaceutical Contract Manufacture Organization is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pharmaceutical Contract Manufacture Organization players cover Lonza, Boehringer Ingelheim, Catalent, Baxter, AbbVie, Pfizer, Evonik, Fareva group and Aenova, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Contract Manufacture Organization market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Active Pharmaceutical Ingredients (APIs)
Finished Dose Formulations (FDFs)
Segmentation by application
Specialty/Midsize
Generics
Big Pharma
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Lonza
Boehringer Ingelheim
Catalent
Baxter
AbbVie
Pfizer
Evonik
Fareva group
Aenova
Almac
Delpharm
Recipharm
Aesica
NIPRO CORPORATION
Daito Pharmaceutical
Teva API
Esteve Quimica
Euticals
Zhejiang Hisun Pharmaceuticals
Please note: The report will take approximately 2 business days to prepare and deliver.